Targeting metabolic vulnerabilities: REV-ERB agonist SR9009 potentiates sorafenib efficacy in liver cancer
Silvia Sabbioni(University of Ferrara), Elisa Callegari(University of Ferrara)
Cited by 2
Related Papers
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer
|Molecular Therapy — Nucleic Acids|2018|23
A comprehensive approach for microbiota and health monitoring in mouse colonies using metagenomic shotgun sequencing
|Animal Microbiome|2021|19
miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models
|Molecular Therapy — Nucleic Acids|2022|14